FDA plans regulatory action on saline breast implants
This article was originally published in Clinica
Executive Summary
Saline breast implant manufacturers in the US are finally being asked to provide the FDA with data on the safety and effectiveness of their products. This is nearly two decades after the agency first suggested that the products needed closer scrutiny because of the potential risks that they pose to women.